Klus Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Klus Pharma General Information

Description

Developer of advanced technology platforms and small molecule-based therapies designed to facilitate innovative biologics and biosimilar programs. The company's platforms are developed in monoclonal antibody, antibody-drug conjugate, fusion protein and polysaccharides, thereby enabling physicians to address unmet medical needs in oncology, autoimmune diseases, liver diseases, diabetes, cardiovascular diseases and anti-infectious diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 101 College Road East, 2F
  • Princeton Forrestal Center
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 101 College Road East, 2F
  • Princeton Forrestal Center
  • Princeton, NJ 08540
  • United States
+1 (609)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Klus Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Klus Pharma‘s full profile, request access.

Request a free trial

Klus Pharma Patents

Klus Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022287001-A1 Antibody drug conjugate, and preparation method therefor and use thereof Pending 02-Jun-2021
CA-3218527-A1 Antibody drug conjugate, and preparation method therefor and use thereof Pending 02-Jun-2021
EP-4349372-A1 Antibody drug conjugate, and preparation method therefor and use thereof Pending 02-Jun-2021
US-20240269312-A1 Antibody drug conjugate, and preparation method therefor and use thereof Pending 02-Jun-2021
WO-2022253035-A1 Antibody drug conjugate, and preparation method therefor and use thereof Inactive 02-Jun-2021 A61K47/6849
To view Klus Pharma’s complete patent history, request access »

Klus Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Klus Pharma FAQs

  • When was Klus Pharma founded?

    Klus Pharma was founded in 2014.

  • Where is Klus Pharma headquartered?

    Klus Pharma is headquartered in Princeton, NJ.

  • What is the size of Klus Pharma?

    Klus Pharma has 11 total employees.

  • What industry is Klus Pharma in?

    Klus Pharma’s primary industry is Drug Discovery.

  • Is Klus Pharma a private or public company?

    Klus Pharma is a Private company.

  • What is the current valuation of Klus Pharma?

    The current valuation of Klus Pharma is .

  • What is Klus Pharma’s current revenue?

    The current revenue for Klus Pharma is .

  • When was Klus Pharma acquired?

    Klus Pharma was acquired on 28-Oct-2016.

  • Who acquired Klus Pharma?

    Klus Pharma was acquired by Sichuan Kelun Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process